Earlier studies have demonstrated that nicotine could enhance proliferation in a range of in vitro cell culture models, an effect that could be blocked by nAChR antagonists, such as the α7 antagonist α-BTX, highlighting α7nAChR as a possible target for cancer therapy [16,45]. The gene discussed is CHRNA7; the disease is cancer.